Hormonal therapy stays the remedy of initial option for metastatic patients with endocrine-responsive breast most cancers (LoE 1a A, In the past ++). The sequential use on the available medication depends on the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at some time of analysis https://johnh320isb9.eveowiki.com/user